Get startedLog in
    Picture of Takeda Pharmaceutical logo

    4502 — Takeda Pharmaceutical News Story

    0.000.00%
    jp flag iconLast trade - 00:00
    HealthcareConservativeLarge CapMomentum Trap
    All News

    Brief: Takeda Announces US Availability Of GAMMAGARD LIQUID ERC, The Only Ready-To-Use Liquid Immunoglobulin Therapy With Low Immunoglobulin A Content1

    Picture of Takeda Pharmaceutical logoTakeda Pharmaceutical
    22/01/2026 12:48
    Jan 22 (Reuters) - Takeda Pharmaceutical Co Ltd 4502.T:

TAKEDA ANNOUNCES U.S. AVAILABILITY OF GAMMAGARD LIQUID ERC, THE ONLY READY-TO-USE LIQUID IMMUNOGLOBULIN THERAPY WITH LOW IMMUNOGLOBULIN A (IGA) CONTENT1

TAKEDA PHARMACEUTICAL CO LTD - AVAILABLE IN 5 G/50 ML AND 10 G/100 ML VIALS

Source text: ID:nBw3VHCCSa

Further company coverage: 4502.T

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Takeda Pharmaceutical

    See all news